SCR-LIP-000165 · Claim · machine-readable JSON →

A narrative review proposes the very-low-calorie ketogenic diet (VLCKD) as a nutritional therapy for lipedema, citing anti-inflammatory effects; reported cases include a 6-month ketogenic diet (Cannataro 2021) yielding 41 kg total weight loss, reduced affected-limb circumferences (e.g., arm -10.5 to -11.5 cm), HOMA-IR reduction of 54%, and CRP reduction of 67%, and the LIPODIET trial (n=9) showing -4.5% weight loss and a 50% VAS pain reduction at 7 weeks that returned to baseline after diet cessation, while noting conventional decongestive therapy reduces tissue volume only 5-10%.

Emerging clinical association Evidence certainty: low (GRADE)

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2023Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema? — Verde et al. (2023) · refines

Evidence (1)

Context (PECO)

Conditionlipedema
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log